KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Guardant Health (GH) Other Working Capital Changes (2017 - 2025)

Guardant Health's Other Working Capital Changes history spans 9 years, with the latest figure at -$15.7 million for Q4 2025.

  • For Q4 2025, Other Working Capital Changes rose 65.31% year-over-year to -$15.7 million; the TTM value through Dec 2025 reached -$212000.0, up 99.41%, while the annual FY2025 figure was -$212000.0, 99.41% up from the prior year.
  • Other Working Capital Changes for Q4 2025 was -$15.7 million at Guardant Health, down from $34.3 million in the prior quarter.
  • Across five years, Other Working Capital Changes topped out at $34.3 million in Q3 2025 and bottomed at -$45.3 million in Q4 2024.
  • The 5-year median for Other Working Capital Changes is -$989000.0 (2021), against an average of -$2.1 million.
  • The largest YoY upside for Other Working Capital Changes was 1097.91% in 2022 against a maximum downside of 11416.84% in 2022.
  • A 5-year view of Other Working Capital Changes shows it stood at $3.9 million in 2021, then plummeted by 501.38% to -$15.8 million in 2022, then soared by 125.48% to $4.0 million in 2023, then crashed by 1229.01% to -$45.3 million in 2024, then soared by 65.31% to -$15.7 million in 2025.
  • Per Business Quant, the three most recent readings for GH's Other Working Capital Changes are -$15.7 million (Q4 2025), $34.3 million (Q3 2025), and -$21.3 million (Q2 2025).